Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesBTC Health Ltd

BTC Health Ltd

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
0.048 AUD 0.00(0%)
Last update at 2026-11-10T23:00:00Z
Market Cap
17.16M

Momentum Score

…

BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cell biology, convergence, silicon biology, and nanomedicine. Within post-genomics, it invests in functional genomics, transcriptomics, proteomics, structural genomics, glycomics, and pharmacogenomics. In the stem cell biology sector, the fund focuses on stem cell therapies. Within convergent technologies, it invests in biomaterials, bionics, biosensors, tissue engineering, microfluidics, and moletronics. In the silicon biology sector, the fund focuses on structure-based drug design, virtual screening, computational library design, and in silico ADME/tox. It invests in companies based in Australia & New Zealand. The fund invests in both listed and unlisted companies.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.05
Low
0.05
High
52 Week Price Range
0.05
Low
0.07
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

BTC Health Ltd is an Australian-listed company associated with the healthcare sector, though detailed public disclosure about its operations, products and strategy is limited. Over the long term the company may benefit from structural healthcare trends such as demographic aging, rising healthcare expenditure and digitalisation that could support demand for clinical services and technologies if BTC executes a clear strategy, and some investors may find sector exposure appealing relative to other ASX listings.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.05
Dividend Yield
-
Revenue TTM
0.03M
Revenue Per Share
-
Gross Profit TTM
0.03M
Debt / Equity
-
ROE
0.34%
Net Debt
-1.47M
ROCE
0.31%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 0.03M 3.98M 1.05M -10.17M -0.58M
Net income 0.03M 3.98M 1.05M -10.17M -0.58M
Selling general administrative 0.22M 0.33M 0.32M 0.32M 0.39M
Selling and marketing expenses 0.13M 0.25M 0.30M 0.14M 0.26M
Gross profit 0.02M 0.01M 0.02M 0.01M 0.10M
Ebit - - 0.40M -10.72M -1.07M
Ebitda 0.03M - 1.05M -10.17M -0.58M
Depreciation and amortization - 0.67M 0.66M 0.55M 0.49M
Operating income 0.03M -0.58M -0.60M -0.45M -0.58M
Other operating expenses 0.01M 0.59M 1.04M 0.46M 0.67M
Interest expense 0.00M - - - 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.03M 0.01M 0.02M 9.62M 0.00M
Net interest income 0.02M 0.01M 0.02M 0.01M 0.00M
Income tax expense - - 1.06M -0.49M -0.49M
Total revenue 0.03M 0.01M 0.02M 0.01M 0.10M
Total operating expenses -0.01M 0.59M -1.04M 0.46M 0.67M
Cost of revenue 0.00M - - - -
Total other income expense net 0.36M 4.56M 1.66M -9.72M 0.00M
Net income from continuing ops 0.03M 3.98M 1.06M -10.17M -0.58M
Net income applicable to common shares - 3.98M 1.06M -10.17M -0.58M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 11.39M 9.36M 5.15M 2.94M 13.02M
Other current assets - - -2.02M 0.00M 0.00M
Total liab 0.18M 0.20M 0.20M 0.16M 0.16M
Total stockholder equity 11.21M 9.16M 4.94M 2.78M 12.86M
Other current liab 0.10M 0.10M - 0.15M 0.10M
Common stock 58.56M - 56.55M 55.67M 55.67M
Capital stock 58.56M 56.61M - 55.67M 55.67M
Retained earnings -48.10M -48.14M -52.12M -53.17M -43.00M
Other assets - - 5.15M - -
Cash 1.47M 0.62M 2.02M 1.74M 2.17M
Cash and equivalents - - - 1.74M 2.17M
Total current liabilities 0.18M 0.20M - 0.16M 0.16M
Current deferred revenue - - - - 0.10M
Net debt -1.47M - -2.02M -1.74M -2.17M
Short term debt - - - 0.00M -0.06M
Other stockholder equity - - - -2.49M -12.66M
Total current assets 1.47M 0.64M - 1.74M 2.20M
Long term investments 7.99M 7.56M - 1.20M 10.82M
Net tangible assets - - - 2.78M 12.86M
Net receivables - - - - 0.03M
Accounts payable 0.02M 0.01M - 0.01M 0.01M
Accumulated other comprehensive income 0.75M - 0.51M 0.29M 0.20M
Non currrent assets other 0.02M - - -1.20M -10.82M
Non current assets total 9.91M 8.72M - 1.20M 10.82M
Long term debt total - - - 0.00M 0.00M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -0.96M -0.20M - -2.00M
Change to liabilities - - - 0.01M 0.01M
Total cashflows from investing activities -0.74M -0.96M -0.20M 0.00M -2.21M
Net borrowings 0.00M - - - -
Total cash from financing activities 1.95M 0.06M 0.89M 0.00M 2.40M
Change to operating activities - - - 0.02M -0.03M
Net income 0.03M 3.98M 1.06M -10.17M -0.58M
Change in cash 0.85M -1.40M 0.29M -0.43M -0.20M
Begin period cash flow 0.62M 2.02M 1.74M 2.17M 2.37M
End period cash flow 1.47M 0.62M 2.02M 1.74M 2.17M
Total cash from operating activities -0.35M -0.50M -0.40M -0.43M -0.39M
Issuance of capital stock 1.95M 0.06M 0.89M - 2.50M
Other cashflows from investing activities - -0.96M -0.20M 0.00M -0.21M
Sale purchase of stock - 0.06M 0.89M 0.00M -0.10M
Other cashflows from financing activities - - -0.20M 0.00M -2.21M
Change to netincome - - - 9.71M 0.20M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital -0.02M -0.00M 0.03M 0.03M -0.02M
Stock based compensation - 0.17M - 0.09M 0.20M
Other non cash items -0.37M -4.65M -1.49M 9.62M 0.19M
Free cash flow -0.35M -0.50M -0.40M -0.43M -0.39M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BTC
BTC Health Ltd		 -
-%		 0.05 - - 583.22 1.53 68.18 392.45
CSL
CSL Ltd		 2.86
1.42%		 204.54 - 22.57 6.15 4.48 4.82 10.06
TLX
TELIX Pharmaceuticals Ltd		 -0.32
2.28%		 13.70 93.87 166.67 5.37 6.37 3.85 47.29
NEU
Neuren Pharmaceuticals Ltd		 -0.30
1.25%		 23.66 154.93 36.36 42.38 7.52 31.95 160.40
MSB
Mesoblast Ltd		 -0.07
3.69%		 1.96 - 454.55 23.43 3.36 18.28 -9.86

Profile*

BTC Health Ltd

BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cell biology, convergence, silicon biology, and nanomedicine. Within post-genomics, it invests in functional genomics, transcriptomics, proteomics, structural genomics, glycomics, and pharmacogenomics. In the stem cell biology sector, the fund focuses on stem cell therapies. Within convergent technologies, it invests in biomaterials, bionics, biosensors, tissue engineering, microfluidics, and moletronics. In the silicon biology sector, the fund focuses on structure-based drug design, virtual screening, computational library design, and in silico ADME/tox. It invests in companies based in Australia & New Zealand. The fund invests in both listed and unlisted companies.

Level 9, Sydney, NSW, Australia, 2000

61 2 8031 7707

https://www.btchealth.com.au

Name Title Year Born
Ms. Sharon Papworth C.A., B.Com., CA CFO & Company Sec. NA
Mr. Oskar Hakansson Bus. Devel. Director NA
Mr. Tim Collins Sales & Marketing Director NA
Mr. Joshua Kahanovitz Head of Finance NA
Mr. Oskar Hakansson Business Development Director NA
Ms. Tracy Weimar BA, MBA Company Secretary NA
Mr. Joshua Kahanovitz Head of Finance NA
Mr. Oskar Hakansson Business Development Director NA
Ms. Tracy Weimar BA, MBA Company Secretary NA
Mr. Joshua Kahanovitz Head of Finance NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…